Odonate Therapeutics, Inc. (ODTC)
Odonate, Inc. is a pharmaceutical company, which engages in the development of therapeutics that improve and extend the lives of patients with cancer. It focuses on the development of tesetaxel, a novel chemotherapy agent that belongs to a class of drugs known as taxanes, which are used in the treatment of cancer. The company was founded in March 2013 and is headquartered in San Diego, CA.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)